INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2024

Authors contend that new antiobesity medications and lifestyle-based behavioral approaches are complementary and must coexist.

This perspective addresses whether new antiobesity medications, such as glucagon-like peptide-1 receptor agonists, render lifestyle-based obesity treatments obsolete. The authors argue that medical approaches affect physiologic pathways that support behavioral treatment success, while behavioral approaches address weight loss-adjacent outcomes not affected by medication. Consequently, they conclude that medical and behavioral approaches are complementary and must coexist to address the obesity epidemic.

Study type
Perspective article
Who was studied
Individuals with obesity
What was measured
Complementary roles of antiobesity medications and behavioral approaches

THE PAPER

Game changers: do new medications make lifestyle-based treatment of obesity obsolete?

Lewis KH, Moore JB, Ard JD. Obesity (Silver Spring), 2024.

PubMed 38044481 ↗DOI 10.1002/oby.23962 ↗

Weight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.